Recommendations for the design of research involving brain surgery
Date
Research news
Date
A study funded by Parkinson’s UK has shown that a handheld device designed to stimulate the vagus nerve is safe and easy to use for people with Parkinson’s. However, the research found no significant improvements to symptoms.
Date
First participants receive NRG drug, further information on Herantis’ treatment and Syntara trial moves towards the data analysis phase.
Date
We achieved so much in 2025. And it’s all thanks to your support.
Date
Early results from a study of the drug developed by AC Immune offer hope that it could slow the progression of Parkinson's symptoms.
Date
A small clinical trial of a probiotic called Symprove shows it helps with non-motor symptoms of Parkinson’s, changes gut bacteria and improves efficiency of medication.
Date
Today we publish new statistics about Parkinson’s in the UK, highlighting gaps in NHS services.
Date
A new research trial will start by testing 2 potential treatments that could slow or even stop Parkinson’s getting worse.
Date
HER-096, a potential new Parkinson's treatment, has shown promising phase 1 trial results, proving it’s safe, well-tolerated, and effective in reaching the brain in people with Parkinson's. This is a crucial step towards a drug that could slow, stop, or even repair Parkinson's damage.
Date
As the leading funder of Parkinson’s research in Europe, we’re pleased to announce that we’re supporting new projects that hope to bring us closer to better treatments to transform the lives of those affected by Parkinson’s.
Date
We’ve awarded Cellestial Health £55,000 to continue exploring networks of brain cells that may hold answers for new treatments for Parkinson’s.